Stay updated on InMed Pharmaceuticals Press Releases

Sign up to get notified when there's something new on the InMed Pharmaceuticals Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the InMed Pharmaceuticals Press Releases page

  1. Check
    6 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has reported its full year fiscal 2024 financial results and provided a business update, while a previous announcement regarding a $5.2 million private placement has been removed.
    Difference
    7%
    Check dated 2024-10-03T04:56:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    InMed has received a NASDAQ delisting notice but is appealing the decision, while notable content regarding its INM-901 Alzheimer's studies and cannabinoid developments has been removed.
    Difference
    8%
    Check dated 2024-09-25T22:32:23.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    35 days ago
    No Change Detected
  6. Check
    42 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has strengthened its patent portfolio with the issuance of three U.S. patents, while the previous report on its fiscal 2023 financial results has been removed.
    Difference
    6%
    Check dated 2024-08-28T02:24:59.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has introduced a new oral formulation, INM-901, targeting Alzheimer's Disease, while also updating their address to 885 West Georgia St., Vancouver.
    Difference
    9%
    Check dated 2024-08-21T00:15:33.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has announced favorable behavioral outcomes with INM-901 in a long-term preclinical Alzheimer's disease study, confirming previous short-term pilot study data, while a previous announcement about their presentation at the H.C. Wainwright conference has been removed.
    Difference
    7%
    Check dated 2024-07-30T22:12:35.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    The values for Epidermolysis Bullosa and Glaucoma have swapped positions with the values for Alzheimer’s Disease and Age-related Macular Degeneration in the recent update on the webpage.
    Difference
    4%
    Check dated 2024-06-21T05:38:49.000Z thumbnail image

Stay in the know with updates to InMed Pharmaceuticals Press Releases

Enter your email address, and we'll notify you when there's something new on the InMed Pharmaceuticals Press Releases page.